MARQUETTE ASSOCIATES, INC.

CIK 0002042617 · CHICAGO, IL · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

MARQUETTE ASSOCIATES, INC. reported 38 positions worth $137.2M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: SPY (14.9%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$137.2M
2026 Q2
Positions
38
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
87.7%
Est. Net Flow (Q)
2026 Q2
10 / 38 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1SPYSTATE STR SPDR S&P 500 ETF TSH$20.4M14.87%27,310
2VTIVANGUARD INDEX FDSSH$18.3M13.35%49,489
3IEFAISHARES TRSH$16.1M11.77%167,143
4AGGISHARES TRSH$15.4M11.25%155,973
5NBOSNEUBERGER BERMAN ETF TRUSTSH$13.0M9.44%462,368
6VXFVANGUARD INDEX FDSSH$11.9M8.69%48,447
7IVVISHARES TRSH$10.9M7.98%14,614
8VOVANGUARD INDEX FDSSH$5.9M4.30%73,265
9BSVVANGUARD BD INDEX FDSSH$5.7M4.18%73,690
10GUNRFLEXSHARES TRSH$2.6M1.91%53,169

The free plan shows the top 10 positions. The remaining 28 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does MARQUETTE ASSOCIATES, INC. hold as of Q2 2026?

MARQUETTE ASSOCIATES, INC. reported 38 positions worth $137.2M in its Q2 2026 13F filing. Largest positions: SPY (14.9%), VTI (13.3%), IEFA (11.8%), AGG (11.3%) and NBOS (9.4%).

What did MARQUETTE ASSOCIATES, INC. buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did MARQUETTE ASSOCIATES, INC. sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.